CD19 Polyclonal Antibody

• Background :

  CD19 is a B cell–specific molecule that controls B cell activation by complexing with the BCR. CD19 is a member of the Ig superfamily and is the dominant component for the signaling complex on B cells that includes CD21, CD81, and CD22.Humans with CD19 deficiency have reduced proliferative responses to BCR stimulation in vitro and mount impaired Ab responses to vaccination.

• Description :

  This is a CD19 Polyclonal Antibody from Reddot Biotech. This product is for Research Use Only.

• Synonyms :

  Antibody deficiency due to defect in CD19, included, AW495831, B lymphocyte antigen CD19, B lymphocyte surface antigen B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, B4, CD19, CD19 antigen, CD19 molecule, Cd19 protein, CD19, CVID3, Differentiation anti

• Swiss Prot :

  P15391, P25918

• Reactivity :

  Human

• Immunogen :

  KLH conjugated Synthetic peptide corresponding to Mouse CD19

• Clonality :

  Polyclonal

• Conjugation :

  Unconjugated

• Type :

  Polyclonal Antibody

• Applications :

  IHC, IF

• Purification Method :

  Affinity purification

• Assay Type :

  Antibody

• Concentration :

  0.54 mg/mL

• Dilution :

  IHC 1:100-1:500, IF 1:100-1:500

• Buffer :

  PBS with 0.02% sodium azide, 1% BSA and 50% glycerol, pH7.4

• Storage Conditions :

  Store at -20°C. Avoid freeze / thaw cycles.

• Host or Source :

  Rabbit

• Isotype :

  IgG